Kalager M - Search Results

1

Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study.

Yu J, Refsum E, Wieszczy P, Helsingen LM, Perrin V, Högdén A, Løberg M, Blom J, Bretthauer M, Adami HO, Ye W, Kalager M. Yu J, et al. Among authors: kalager m. BMJ Open Gastroenterol. 2023 May;10(1):e001037. doi: 10.1136/bmjgast-2022-001037. BMJ Open Gastroenterol. 2023. PMID: 37142293 Free PMC article.

2

[Survival after breast cancer--differences between Norwegian counties].

Kalager M, Kåresen R, Wist E. Kalager M, et al. Tidsskr Nor Laegeforen. 2009 Dec 17;129(24):2595-600. doi: 10.4045/tidsskr.09.0024. Tidsskr Nor Laegeforen. 2009. PMID: 20029554 Free article. Norwegian.

3

Letter to the Editor: Hofvind S, Skaane P. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening. Fortschr Röntgenstr 2012; 184: 437-442.

Kalager M. Kalager M. Rofo. 2012 Aug;184(8):746; author reply 746-7. doi: 10.1055/s-0032-1313010. Epub 2012 Jul 31. Rofo. 2012. PMID: 22851265 No abstract available.

4

[Share data].

Kalager M. Kalager M. Tidsskr Nor Laegeforen. 2017 May 23;137(10):679. doi: 10.4045/tidsskr.17.0446. eCollection 2017 May. Tidsskr Nor Laegeforen. 2017. PMID: 28551946 Free article. Norwegian. No abstract available.

5

Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk.

Kalager M. Kalager M. Evid Based Nurs. 2014 Jan;17(1):7-8. doi: 10.1136/eb-2013-101281. Epub 2013 Sep 3. Evid Based Nurs. 2014. PMID: 24001593 No abstract available.

6

Comparing attendees with non-attendees in breast screening does not provide useful information about an effect on prognostic features or mortality.

Jørgensen KJ, Kalager M, Zahl PH, Fønnebø VM. Jørgensen KJ, et al. Among authors: kalager m. Breast Cancer Res Treat. 2012 Nov;136(2):617-8, author reply 619-20. doi: 10.1007/s10549-012-2250-y. Epub 2012 Sep 26. Breast Cancer Res Treat. 2012. PMID: 23011508 No abstract available.

7

Clinical decisions. Mammography screening for breast cancer.

Smith RA, Kerlikowske K, Miglioretti DL, Kalager M. Smith RA, et al. Among authors: kalager m. N Engl J Med. 2012 Nov 22;367(21):e31. doi: 10.1056/NEJMclde1212888. N Engl J Med. 2012. PMID: 23171121 No abstract available.

8

Systematic review with meta-analysis: the incidence of advanced neoplasia after polypectomy in patients with and without low-risk adenomas.

Hassan C, Gimeno-García A, Kalager M, Spada C, Zullo A, Costamagna G, Senore C, Rex DK, Quintero E. Hassan C, et al. Among authors: kalager m. Aliment Pharmacol Ther. 2014 May;39(9):905-12. doi: 10.1111/apt.12682. Epub 2014 Mar 4. Aliment Pharmacol Ther. 2014. PMID: 24593121 Free article. Review.

9

Regression of screening-detected breast cancer.

Kalager M. Kalager M. Lancet Oncol. 2011 Nov;12(12):1083-4. doi: 10.1016/S1470-2045(11)70262-5. Epub 2011 Oct 11. Lancet Oncol. 2011. PMID: 21996167 No abstract available.

10

[StatMed – the new oil?].

Kalager M. Kalager M. Tidsskr Nor Laegeforen. 2019 May 27;139(9). doi: 10.4045/tidsskr.19.0349. Print 2019 May 28. Tidsskr Nor Laegeforen. 2019. PMID: 31140239 Free article. Norwegian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters